SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]:
SEC Accession No. 0001193125-09-125867
Filing Date
2009-06-05
Accepted
2009-06-05 11:24:29
Documents
11
Period of Report
2008-12-31

Document Format Files

Seq Description Document Type Size
1 FORM 20-F d20f.htm 20-F 1570614
2 ARTICLES OF ASSOCIATION OF EVOTEC AG dex11.htm EX-1.1 67602
3 LICENSE AGREEMENT dex410.htm EX-4.10 298290
4 ASSET PURCHASE AGREEMENT dex411.htm EX-4.11 262328
5 FIRST AMENDMENT TO THE LICENSE AGREEMENT EFFECTIVE MARCH 18, 2005 dex412.htm EX-4.12 25682
6 RESEARCH AND COLLABORATION AGREEMENT dex413.htm EX-4.13 252822
7 LIST OF SIGNIFICANT SUBSIDIARIES AND ASSOCIATED COMPANIES OF EVOTEC AG dex81.htm EX-8.1 3953
8 CERTIFICATION OF THE CEO UNDER SECTION 302 dex121.htm EX-12.1 8856
9 CERTIFICATION OF THE CFO UNDER SECTION 302 dex122.htm EX-12.2 8847
10 CERTIFICATION OF THE CEO AND THE CFO UNDER SECTION 906 dex131.htm EX-13.1 4556
11 CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM dex151.htm EX-15.1 2069
  Complete submission text file 0001193125-09-125867.txt   2506993
Mailing Address SCHNACKENBURGALLE 114 HAMBURG 2M 22525
Business Address SCHNACKENBURGALLE 114 HAMBURG 2M 22525 49-40-560-810
Evotec AG (Filer) CIK: 0001412558 (see all company filings)

IRS No.: 000000000 | State of Incorp.: 2M | Fiscal Year End: 1231
Type: 20-F | Act: 34 | File No.: 001-34041 | Film No.: 09875928
SIC: 2834 Pharmaceutical Preparations